Indications for use
Bronchosol MAXIPUREN is used:
– as an adjuvant in common cold and inflammations of the upper respiratory tract with accompanying cough, rhinitis and difficult expectoration of viscous mucus;
– as an adjuvant in non-purulent rhinosinusitis.
The product is indicated in adults and adolescents from 12 years of age.
One capsule of the medicinal product Bronchosol MAXIPUREN contains 200 mg Eucalyptus globulus Labill, Eucalyptus polybractea R.T. Baker, Eucalyptus smithii R.T. Baker, aetheroleum (eucalyptus oil).
Excipients with known effect:
sorbitol 70%; one capsule contains up to 14.77 mg of sorbitol,
propylene glycol; one capsule contains 5.20 mg of propylene glycol.
Dosage form and packaging
Packaging: 30 capsules
Hypersensitivity to eucalyptus oil, its constituents (1,8-cineol) or to any of the excipients.
Dosage and route of administration
Children under 12 years of age: Do not use.
Duration of treatment: Bronchosol MAXIPUREN should be used until symptoms resolve, usually for 1 week.
Method of administration: Take the drug 15 minutes before a meal with water. Swallow whole, do not chew.
Duration of use: Consult a doctor if the symptoms persist or worsen after 7 days.
MARKETING AUTHORISATION HOLDER
Phytopharm Klęka S.A., Klęka 1, 63-040 Nowe Miasto nad Wartą